LY248686, A New Inhibitor of Serotonin and Norepinephrine Uptake, Neuropsychopharmacology, vol.8, issue.1, pp.23-33, 1993. ,
DOI : 10.1038/npp.1993.4
Meta-analyses of duloxetine in the treatment of MDD [Poster]. presented at the 4th International Forum on Mood and Anxiety Disorders : abstract PO13, 2003. ,
Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine, Clinical Therapeutics, vol.26, issue.9, pp.1446-1455, 2004. ,
DOI : 10.1016/j.clinthera.2004.09.010
Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder, Journal of Psychiatric Research, vol.39, issue.1, pp.43-53, 2005. ,
DOI : 10.1016/j.jpsychires.2004.04.011
The generalization of the odds ratio, risk ratio and risk difference tor ???k tables, Statistics in Medicine, vol.14, issue.14, pp.1901-1914, 2000. ,
DOI : 10.1002/1097-0258(20000730)19:14<1901::AID-SIM514>3.0.CO;2-V
Indirect comparisons of competing interventions, Health Technology Assessment, vol.9, issue.26, p.9, 2005. ,
DOI : 10.3310/hta9260
Advanced methods in meta-analysis: multivariate approach and meta-regression, Statistics in Medicine, vol.14, issue.4, pp.589-624, 2002. ,
DOI : 10.1002/sim.1040
Efficacy of duloxetine in patients with mild, moderate, or severe depressive symptoms, Poster]. presented at the 158th Annual Meeting of the American Psychiatric Association. Abstract NR363, 2005. ,
Duloxetine in the Treatment of Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.63, issue.3, pp.225-231, 2002. ,
DOI : 10.4088/JCP.v63n0309
Duloxetine, 60 mg Once Daily, for Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.63, issue.4, pp.308-315, 2002. ,
DOI : 10.4088/JCP.v63n0407
Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression, Journal of Psychiatric Research, vol.36, issue.6, pp.383-390, 2002. ,
DOI : 10.1016/S0022-3956(02)00060-2
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial, European Neuropsychopharmacology, vol.14, issue.6, pp.457-470, 2004. ,
DOI : 10.1016/j.euroneuro.2004.01.002
Duloxetine in the Treatment of Depression, Journal of Clinical Psychopharmacology, vol.24, issue.4, pp.389-399, 2004. ,
DOI : 10.1097/01.jcp.0000132448.65972.d9
Efficacy of fluoxetine in outpatients with major depression, Curr Ther Res, vol.37, pp.115-123, 1985. ,
A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder, J Clin Psychiatry, vol.46, pp.53-58, 1985. ,
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder, J Clin Psychiatry, vol.46, pp.26-31, 1985. ,
Fluoxetine Response: Endpoint vs Pattern Analysis, International Clinical Psychopharmacology, vol.1, issue.4, pp.320-323, 1986. ,
DOI : 10.1097/00004850-198610000-00006
Fluoxetine in major depression : a controlled study, Curr Ther Res, vol.39, pp.559-563, 1986. ,
Doubleblind treatment of major depression with fluoxetine: use of pattern analysis and relation of HAM-D score to CGI change, Psychopharmacol Bull, vol.23, pp.162-163, 1987. ,
Fixed-dose fluoxetine therapy for depression, Psychopharmacol Bull, vol.23, pp.164-168, 1987. ,
A fixed-dose clinical trial of fluoxetine in outpatients with major depression, J Clin Psychiatry, vol.48, pp.406-408, 1987. ,
Low-dose fluoxetine therapy for depression, Psychopharmacol Bull, vol.24, pp.183-188, 1988. ,
Fluoxetine-induced reduction of body mass in patients with major depressive disorder, Psychopharmacol Bull, vol.24, pp.220-223, 1988. ,
Fluoxetine, a Selective Serotonin Uptake Inhibitor, for the Treatment of Outpatients with Major Depression, Journal of Clinical Psychopharmacology, vol.8, issue.2, pp.112-115, 1988. ,
DOI : 10.1097/00004714-198804000-00005
A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients, Acta Psychiatrica Scandinavica, vol.19, issue.1, pp.384-390, 1988. ,
DOI : 10.1007/BF00177927
A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression, International Clinical Psychopharmacology, vol.4, issue.2, pp.127-134, 1989. ,
DOI : 10.1097/00004850-198904000-00004
Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression, Psychopharmacol Bull, vol.26, pp.173-180, 1990. ,
A double-blind, placebo controlled clinical trial to evaluate efficacy and safety of fluoxetine in the treatment of major depression, G Ital Ric Clin Ther, vol.13, pp.59-64, 1992. ,
Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo, Journal of Affective Disorders, vol.30, issue.3, pp.163-173, 1994. ,
DOI : 10.1016/0165-0327(94)90077-9
Placebo-controlled study of ABT-200 versus fluoxetine in the treatment of major depressive disorder, Depression, vol.4, issue.4, pp.199-203, 1995. ,
DOI : 10.1002/depr.3050030407
A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo in Outpatients with Major Depression, Annals of Clinical Psychiatry, vol.10, issue.4, pp.145-150, 1998. ,
DOI : 10.3109/10401239809147030
A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression, Journal of Affective Disorders, vol.56, issue.2-3, pp.171-181, 1999. ,
DOI : 10.1016/S0165-0327(99)00067-1
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression, Depression and Anxiety, vol.115, issue.2, pp.58-65, 2000. ,
DOI : 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H
A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine, Clinical Therapeutics, vol.23, issue.7, pp.1040-1058, 2001. ,
DOI : 10.1016/S0149-2918(01)80090-4
Venlafaxine in depressed outpatients, Psychopharmacol Bull, vol.27, pp.141-144, 1991. ,
Placebo-Controlled Trial of Venlafaxine for the Treatment of Major Depression, Journal of Clinical Psychopharmacology, vol.11, issue.4, pp.233-236, 1991. ,
DOI : 10.1097/00004714-199108000-00002
A comparison of venlafaxine, trazodone, and placebo in major depression [published erratum appears, J Clin Psychopharmacol, vol.14, issue.4, p.292, 1994. ,
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients, J Clin Psychiatry, vol.55, pp.104-108, 1994. ,
Once-Daily Venlafaxine Extended Release (XR) and Venlafaxine Immediate Release (IR) in Outpatients with Major Depression, Annals of Clinical Psychiatry, vol.9, issue.3, pp.157-164, 1997. ,
DOI : 10.3109/10401239709147791
Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major Depression, The Journal of Clinical Psychiatry, vol.58, issue.9, pp.393-398, 1997. ,
DOI : 10.4088/JCP.v58n0904
Once-Daily Venlafaxine Extended Release (XR) Compared With Fluoxetine in Outpatients With Depression and Anxiety, The Journal of Clinical Psychiatry, vol.60, issue.1, pp.22-28, 1999. ,
DOI : 10.4088/JCP.v60n0105
Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach, Clinical Therapeutics, vol.23, issue.6, pp.942-956, 2001. ,
DOI : 10.1016/S0149-2918(01)80082-5
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses, BMJ, vol.326, issue.7387, p.472, 2003. ,
DOI : 10.1136/bmj.326.7387.472
PMH44 DULOXETINE AND VENLAFAXINE-XR IN THE TREATMENT OF MDD: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS, Value in Health, vol.8, issue.6, pp.391798-807, 2005. ,
DOI : 10.1016/S1098-3015(10)67790-X
Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder, Annals of Internal Medicine, vol.143, issue.6, pp.415-426, 2005. ,
DOI : 10.7326/0003-4819-143-6-200509200-00006
Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression, The British Journal of Psychiatry, vol.176, issue.5, pp.421-428, 2000. ,
DOI : 10.1192/bjp.176.5.421
A meta-analysis of fluoxetine outcome in the Treatment of depression. The journal of Nervous and Mental Disease, pp.547-551, 1994. ,
Indirect Comparison in Evaluating Relative Efficacy Illustrated by Antimicrobial Prophylaxis in Colorectal Surgery, Controlled Clinical Trials, vol.21, issue.5, pp.488-497, 2000. ,
DOI : 10.1016/S0197-2456(00)00055-6
Users' Guides to the Medical Literature, JAMA, vol.282, issue.14, pp.1371-1377, 1999. ,
DOI : 10.1001/jama.282.14.1371
Bias in meta-analysis detected by a simple, graphical test, BMJ, vol.315, issue.7109, pp.629-634, 1997. ,
DOI : 10.1136/bmj.315.7109.629
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis, BMJ, vol.321, issue.7273, pp.1371-1376, 2000. ,
DOI : 10.1136/bmj.321.7273.1371